Search results
Results from the WOW.Com Content Network
The protracted withdrawal syndrome from benzodiazepines, opioids, alcohol and other addictive substances can produce symptoms identical to generalized anxiety disorder as well as panic disorder. Due to the sometimes prolonged nature and severity of benzodiazepine, opioid and alcohol withdrawal, abrupt cessation is not advised.
Alcohol withdrawal syndrome (AWS) is a set of symptoms that can occur following a reduction in alcohol use after a period of excessive use. [1] Symptoms typically include anxiety , shakiness , sweating, vomiting, fast heart rate , and a mild fever. [ 1 ]
Periorbital puffiness, also known as puffy eyes, or swelling around the eyes, is the appearance of swelling in the tissues around the eyes, called the orbits. It is almost exclusively caused by fluid buildup around the eyes, or periorbital edema. Minor puffiness usually detectable below the eyes only is often called eye bags.
Lack of sleep, salty food, age, and genetics can cause puffy eyes. Here, dermatologists share causes, risk factors, treatment, and prevention for eye swelling.
Alcohol inhibits your ability to reach a REM state while asleep, so after a few days without alcohol, you’ll start to notice that you’re dreaming more and getting deeper, more restorative rest ...
There are a few factors that can cause puffy eyes. As mentioned, puffy eyes can be caused by a lack of sleep, consumption of lots of salt or alcohol, excessive rubbing of the eyes, allergies and ...
Management with a combination of abstinence from alcohol and the use of neuroleptics has been shown to be effective. [11] It is also possible to treat withdrawal before major symptoms start to happen in the body. Diazepam and chlordiazepoxide have proven to be effective in treating alcohol withdrawal symptoms such as alcoholic hallucinosis ...
Failure to manage the alcohol withdrawal syndrome appropriately can lead to permanent brain damage or death. [ 11 ] Acamprosate , a drug used to promote abstinence from alcohol, an NMDA antagonist drug, reduces excessive glutamate activity in the central nervous system and thereby may reduce excitotoxicity and withdrawal related brain damage.